ClinicalTrials.gov Identifier: NCT04990141
PREMOM Clinical Study
We have conducted a prospective clinical study to demonstrate sensitivity and specificity of circulating RNA for the early screening of preeclampsia and other pregnancy complications
PROSPECTIVE CLINICAL STUDY
We have conducted a multicenter study involving 14 hospitals and more than 100 health professionals dedicated to the recruitment of pregnant women
100
PATIENT ENROLLMENT ACHIEVED
9,600
Women recruited
9,583
Women who have completed the study
26,185
Total samples
We have enrolled more than 9,500 pregnant women and collected more than 26,000 peripheral blood samples at three specific points during pregnancy
PREECLAMPSIA SCREENING TEST
This clinical trial has enabled the development of a blood test to predict pregnancy complications early before the first symptoms appear
Blood Sample Processing
Isolating RNA molecules circulating in peripheral blood
NGS sequencing
Decoding all the RNA molecules isolated using innovative technologies
Molecular profiling
Unveiling the biology underlying pregnancy based on the RNA profile
Preeclampsia prediction
Risk assessment during the first trimester of pregnancy
Our research brings us closer to a world where pregnant women do not fear for their health
Click the button below for more information about taking part in the trial. We will provide you with all the information you may need and evaluate your eligibility, obligation free!
Simply contacting or responding to this announcement does not commit you to participate but only expresses your desire to obtain more information regarding this study
